In PCa oncogenesis, the miR-15a/16-1 cluster acts as a tumour suppressor by targeting multiple oncogenes, including BCL2, CCND1, and WINT3A (Bonci et al, 2008). The gene discussed is BCL2; the disease is posterior cortical atrophy.